Ormeloxifene–Looking beyond contraception

T Pati, K Chanania, S Marandi… - Journal of Mid-Life Health, 2017 - journals.lww.com
Aims: This study is aimed at finding out a logical solution for perimenopausal menorrhagia in
normal or bulky uterus. Settings and Design: The study is carried out at a tertiary care …

Comparative study of low-dose oral contraceptive pill and ormeloxifene in the treatment of dysfunctional uterine bleeding

D Mandal, S Parmanik, S Surana, A Hazra… - International Journal of …, 2014 - go.gale.com
Background: Role of oral contraceptive pill (OCP) and ormeloxifene (ORM) in dysfunctional
uterine bleeding (DUB) is still in an exploring level. Aim: The aim was to observe the …

The effect of centchroman on mastalgia: a systematic review

N Ghassab-Abdollahi, M Mirghafourvand… - … European Journal of …, 2019 - Taylor & Francis
Objectives: We carried out a systematic review of the literature to evaluate the effect of
centchroman on mastalgia as well as any side effects. Methods: The databases of the …

[PDF][PDF] Efficacy and Safety of Ormeloxifene versus low dose OCP in the treatment of Abnormal Uterine Bleeding (AUB)

S Sinha, MC Regmi, T Pradhan - J Med Sci Clin Res, 2020 - researchgate.net
Abstract Background and Objective: Abnormal uterine bleeding are a common problem that
not only affects the quality of life but can have serious adverse consequences as anemia …

Ormeloxifene versus Tranexamic acid in dysfunctional uterine bleeding comparative evaluation

K Hymavathi, MD Gottipati, V Sudha - International Journal of …, 2018 - go.gale.com
Background: Dysfunctional Uterine bleeding (DUB) is the most common cause of abnormal
uterine bleeding (AUB). Medical therapy being the first line of management, an ideal drug …

Comparative study to evaluate efficacy of 30 mg of ormeloxifene to 60 mg of ormeloxifene in cases of dysfunctional uterine bleeding

PV Dhakne, AS Gupta - International Journal of Reproduction …, 2016 - go.gale.com
Background: Dysfunctional uterine bleeding is most common menstrual disorder. Third
generation selective estrogen receptor modulator ormeloxifene is relatively recent modality …

[PDF][PDF] Ormeloxifene versus oral contraceptive pills in the management of DUB

V Arunadevi, SNS Minnalkodi - International Journal of …, 2020 - gynaecologyjournal.com
Background: DUB is defined as abnormal uterine bleeding without any clinically detectable
pelvic pathology. The present study was conducted to compare the efficacy and safety of …

Efficacy and safety of ormeloxifene, a selective estrogen receptor modulator in management of dysfunctional uterine bleeding in perimenopausal patients: a …

N Shrivastava, R Rani - International Journal of Reproduction …, 2023 - go.gale.com
Background: Dysfunctional uterine bleeding (DUB) is one of the most common menstrual
disorder of women in any age group and is a diagnosis of exclusion. Medical management …

Study of the efficacy of ormeloxifene in abnormal uterine bleeding.

PB Varwatte, M Fonseca - International Journal of Reproduction …, 2020 - go.gale.com
Background: Abnormal uterine bleeding (AUB) is a diagnosis that does not apply to
menorrhagia only, but also includes (menometrorrhagia) excessively prolonged and …

[PDF][PDF] The role of Ormeloxifene in the Management of Dysfunctional Uterine Bleeding: A Prospective Clinical Study

A Kumari, R Prakash - International Journal of Contemporary …, 2018 - researchgate.net
Introduction: The term dysfunctional uterine bleeding (DUB) is used for abnormal uterine
bleeding occurring in the absence of identifiable pathology. A number of drugs are available …